Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 62 Records) |
| Query Trace: Myelodysplastic Syndromes and TET2[original query] |
|---|
| Distinct clinical and biological implications of CUX1 in myeloid neoplasms. Blood advances 2019 7 3 (14): 2164-2178. Aly Mai, Ramdzan Zubaidah M, Nagata Yasunobu, Balasubramanian Suresh K, Hosono Naoko, Makishima Hideki, Visconte Valeria, Kuzmanovic Teodora, Adema Vera, Nazha Aziz, Przychodzen Bartlomiej P, Kerr Cassandra M, Sekeres Mikkael A, Abazeed Mohamed E, Nepveu Alain, Maciejewski Jaroslaw |
| Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation. Annals of hematology 2019 Jul . Caballero Juan Carlos, Sánchez Barba Mercedes, Hernández Sánchez Jesús María, Such Esperanza, Janusz Kamila, Sanz Guillermo, Cabrero Mónica, Chillón Carmen, Cervera José, Hurtado Ana María, Jerez Andrés, Calderón Cabrera Cristina, Valcárcel David, Lumbreras Eva, Abáigar María, López Cadenas Félix, Hernández Rivas Jesús María, Del Cañizo María Consuelo, Díez Campelo Mar |
| Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes. Cancer science 2019 Dec . Jiang Lingxu, Luo Yingwan, Zhu Shuanghong, Wang Lu, Ma Liya, Zhang Hua, Shen Chuying, Yang Wenli, Ren Yanling, Zhou Xinping, Mei Chen, Ye Li, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
| Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome. Journal of clinical pathology 2019 11 73 (4): 209-212. Badaat Ibraahim, Mirza Sabbir, Padron Eric, Sallman David, Komrokji Rami, Song Jinming, Hussaini Mohammad |
| Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern. Blood advances 2019 Oct 3 (20): 3111-3122. Berger Gerbrig, Gerritsen Mylene, Yi Guoqiang, Koorenhof-Scheele Theresia N, Kroeze Leonie I, Stevens-Kroef Marian, Yoshida Kenichi, Shiraishi Yuichi, van den Berg Eva, Schepers Hein, Huls Geert, Mulder André B, Ogawa Seishi, Martens Joost H A, Jansen Joop H, Vellenga E |
| [Analysis of mutations of 14 genes among 87 patients with myelodysplastic syndrome]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 10 36 (10): 953-956. Zhou Xuyan, Jin He, Mu Qitian, Sheng Lixia, Lai Binbin, Zhu Huiling, Ouyang Guifa |
| Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation. Hematology (Amsterdam, Netherlands) 2020 6 25 (1): 211-218. Wang Kai, Zhou Feng, Cai Xiaohui, Chao Hongying, Zhang Ri, Chen Suni |
| [Features and clinical significance of gene mutations in patients with myelodysplastic syndromes with ring sideroblasts]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2020 6 41 (5): 379-386. Cai Y N, Xu Z F, Li B, Qin T J, Pan L J, Qu S Q, Hu N B, Liu D, Huang H J, Shi Z X, Zhang Y D, Xiao Z |
| Cryptic aberrations may allow more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution. Genes, chromosomes & cancer 2020 3 59 (7): 396-405. Svobodova Karla, Lhotska Halka, Hodanova Lucie, Pavlistova Lenka, Vesela Denisa, Belickova Monika, Vesela Jitka, Brezinova Jana, Sarova Iveta, Izakova Silvia, Lizcova Libuse, Siskova Magda, Jonasova Anna, Cermak Jaroslav, Michalova Kyra, Zemanova Zuza |
| Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2-mutated neoplasms. Leukemia 2020 12 35 (8): 2371-2381. Todisco Gabriele, Creignou Maria, Gallì Anna, Guglielmelli Paola, Rumi Elisa, Roncador Marco, Rizzo Ettore, Nannya Yasuhito, Pietra Daniela, Elena Chiara, Bono Elisa, Molteni Elisabetta, Rosti Vittorio, Catricalá Silvia, Sarchi Martina, Dimitriou Marios, Ungerstedt Johanna, Vannucchi Alessandro Maria, Hellström-Lindberg Eva, Ogawa Seishi, Cazzola Mario, Malcovati Lu |
| Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis. Haematologica 2021 9 107 (8): 1815-1826. Gutierrez-Rodrigues Fernanda, Beerman Isabel, Groarke Emma M, Patel Bhavisha A, Spitofsky Nina, Dillon Laura W, Raffo Diego Quinones, Hourigan Christopher S, Kajigaya Sachiko, Ferrucci Luigi, Young Neal |
| The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm. International journal of laboratory hematology 2021 7 43 (6): 1501-1509. Ibrar Warda, Zhang Weiwei, Cox Jesse Lee, Cushman-Vokoun Allison, Fu Kai, Greiner Timothy C, Yuan |
| [Predisposition and progression of myelodysplastic syndromes]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2021 5 62 (4): 278-288. Makishima Hide |
| Mutations in chronic myelomonocytic leukemia and their prognostic relevance. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 4 23 (9): 1731-1742. Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu |
| Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes. Blood advances 2021 2 5 (4): 1017-1028. Hunter Anthony M, Komrokji Rami S, Yun Seongseok, Al Ali Najla, Chan Onyee, Song Jinming, Hussaini Mohammad, Talati Chetasi, Sweet Kendra L, Lancet Jeffrey E, Padron Eric, List Alan F, Sallman David |
| Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes. Asian Pacific journal of cancer prevention : APJCP 2021 12 22 (12): 4037-4042. Hattakitpanitchakul Saroj, Kobbuaklee Sirorat, Wudhikarn Kitsada, Polprasert Chanta |
| [Characteristics and Clinical Significance of Gene Mutation in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2021 12 29 (6): 1864-1868. Zhao Fang, Wang Kai-Li, Qin Yu-Ting, Nilupar Tuerxun, Patiguli Abulizi, Jiang Ming, Hao Jian-Pi |
| TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes. Blood advances 2021 11 6 (1): 100-107. Gurnari Carmelo, Pagliuca Simona, Guan Yihong, Adema Vera, Hershberger Courtney E, Ni Ying, Awada Hassan, Kongkiatkamon Sunisa, Zawit Misam, Coutinho Diego F, Zalcberg Ilana R, Ahn Jae-Sook, Kim Hyeoung-Joon, Kim Dennis Dong Hwan, Minden Mark D, Jansen Joop H, Meggendorfer Manja, Haferlach Claudia, Jha Babal K, Haferlach Torsten, Maciejewski Jaroslaw P, Visconte Valer |
| Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series. Frontiers in immunology 2021 10 12 715053. Martin de Frémont Grégoire, Hirsch Pierre, Gimenez de Mestral Santiago, Moguelet Philippe, Ditchi Yoan, Emile Jean-François, Senet Patricia, Georgin-Lavialle Sophie, Hanslik Thomas, Maurier François, Adedjouma Amir, Abisror Noémie, Mahevas Thibault, Malard Florent, Adès Lionel, Fenaux Pierre, Fain Olivier, Chasset François, Mekinian Arsè |
| Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromes. American journal of cancer research 2020 10 (12): 4476-4487. Jiang Lingxu, Wang Lu, Shen Chuying, Zhu Shuanghong, Lang Wei, Luo Yingwan, Zhang Hua, Yang Wenli, Han Yueyuan, Ma Liya, Ren Yanling, Zhou Xinping, Mei Chen, Ye Li, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
| ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial. International journal of hematology 2022 7 116 (5): 659-668. Morita Yasuyoshi, Nannya Yasuhito, Ichikawa Motoshi, Hanamoto Hitoshi, Shibayama Hirohiko, Maeda Yoshinobu, Hata Tomoko, Miyamoto Toshihiro, Kawabata Hiroshi, Takeuchi Kazuto, Tanaka Hiroko, Kishimoto Junji, Miyano Satoru, Matsumura Itaru, Ogawa Seishi, Akashi Koichi, Kanakura Yuzuru, Mitani Kinu |
| Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes. Scientific reports 2022 4 12 (1): 5925. Maurya Nehakumari, Mohanty Purvi, Dhangar Somprakash, Panchal Purvi, Jijina Farah, Mathan S Leo Prince, Shanmukhaiah Chandrakala, Madkaikar Manisha, Vundinti Babu R |
| Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience. Frontiers in oncology 2022 4 12 795955. Fattizzo Bruno, Levati Giorgia Virginia, Giannotta Juri Alessandro, Cassanello Giulio, Cro Lilla Marcella, Zaninoni Anna, Barbieri Marzia, Croci Giorgio Alberto, Revelli Nicoletta, Barcellini Wil |
| Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation. BMC cancer 2022 3 22 (1): 262. Wu Xia, Deng Jili, Zhang Nanchen, Liu Xiaoyan, Zheng Xue, Yan Tianyou, Ye Wu, Gong Yupi |
| New genetic variants of TET2 and ASXL1 identified by next generation sequencing and pyrosequencing in a patient with MDS-RS-MLD and secondary acute myeloid leukemia. Central-European journal of immunology 2022 2 46 (4): 524-530. Adamska Monika Ma?gorzata, Kowal-Wi?niewska Ewelina, Kiwerska Katarzyna, Ustaszewski Adam, Czerwi?ska-Rybak Joanna, Kandu?a Zuzanna, Wojtaszewska Marzena, Bara?ska Marta, Pruchniewski ?ukasz, Lewandowski Krzysztof, Jarmu?-Szymczak Ma?gorzata, Gil Lid |
| Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes. Hematological oncology 2022 11 . Lee Wan-Hsuan, Lin Chien-Chin, Wang Yu-Hung, Yao Chi-Yuan, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Peng Yen-Ling, Hsu Cheng-An, Sun Hsun-I, Chuang Yi-Kuang, Hsu Chia-Lang, Tien Feng-Ming, Tsai Cheng-Hong, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fa |
| IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons???60 years with myelodysplastic syndromes. Experimental hematology & oncology 2022 Oct 11 (1): 73. Wu Junying, Zhang Yudi, Qin Tiejun, Xu Zefeng, Qu Shiqiang, Pan Lijuan, Li Bing, Jia Yujiao, Li Chengwen, Wang Huijun, Gao Qingyan, Cai Wenyu, Gong Jingye, Zhao Songyang, Li Fuhui, Gale Robert Peter, Xiao Zhiji |
| Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management. American journal of hematology 2022 1 97 (3): 352-372. Patnaik Mrinal M, Tefferi Ayal |
| Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes. Journal of cancer research and clinical oncology 2022 1 148 (4): 845-856. Jiang Lingxu, Ye Li, Ma Liya, Ren Yanling, Zhou Xinping, Mei Chen, Xu Gaixiang, Yang Haiyang, Lu Chenxi, Luo Yingwan, Zhu Shuanghong, Wang Lu, Shen Chuying, Yang Wenli, Zhang Qi, Wang Yuxia, Lang Wei, Han Yueyuan, Jin Jie, Tong Hongy |
| Clinical implications of myeloid malignancy?related somatic mutations in aplastic anemia. Clinical and experimental medicine 2023 4 . Lingling Liu, Danfeng Zhang, Qiuhao Fu, Jingdi Wang, Jifeng Yu, Dandan Chen, Fang Wang, Rong Guo, Xinsheng Xie, Zhongxing Jiang, Yingmei |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: